Project Grant HT94252410280
Award Date 5/1/24
Completion Date 4/30/28
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
- The Defense Health Agency awarded a $4,319,388 Project Grant to the University of Melbourne to fund research aimed at "TARGETING SENESCENT CELLS TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS" over the period from September 1, 2024 to August 31, 2028. This grant is provided under the Military Medical Research and Development Program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
- The University of Melbourne was awarded a $768,263 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on developing a novel inhibitor of ribosome biogenesis with antitumor activity in preclinical models of prostate cancer. The goal of the Military Medical Research and Development program is to transform military and public health through innovative medical research solutions. This award will...
- The University of Melbourne was awarded an $854,195 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support integrative molecular characterization and biomarker validation research in metastatic hormone-sensitive prostate cancer from September 2021 through August 2025. Through this funding, the University of Melbourne will conduct basic, applied, and advanced biomedical research to investigate medical...
- The University of Melbourne was awarded a $591,778 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Harnessing the Immune Response in Exceptionally Long-Term Survivors to Develop Novel Therapeutics." The project will run from May 1, 2024 to April 30, 2027. The University of Melbourne has a history of conducting federal research and consulting work in areas such as...
- This federal Project Grant award in the amount of $733,068.00 was issued by the Defense Health Agency to the University of Melbourne on September 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project titled "Investigating Transcript Diversity as a Driver of Melanoma Progression and Recurrence." The University of Melbourne will conduct basic, translational, and clinical research aimed at developing new...
- The Department of the Army Medical Command awarded $608,341 to Monash University under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2022 through September 14, 2025. The project grant funding will support Monash University's research efforts to elucidate and suppress cells of origin of cutaneous melanoma. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- Federal Grant Award Summary The University of Queensland has been awarded $1,156,726 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year research project spanning September 1, 2025, through August 31, 2028. The project, titled "Predicting Early-Stage Melanoma at High Risk of Recurrence Through Multiomics Profiling," focuses on developing innovative diagnostic capabilities to identify melanoma patients at...
- The U.S. Defense Health Agency has awarded a $367,622 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to St. Vincent's Institute of Medical Research, a foreign-owned non-profit organization based in Australia. The grant supports a 2-year research project focused on studying the reprogramming of mRNA translation as a driver of drug resistance in ovarian cancer. The research aims to transform healthcare for military service members and the broader public...
- This $125,050 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of New South Wales (UNSW) to investigate the use of UDP-glucose in inducing ovarian cancer cell death and promoting antitumor immunity. The research aims to advance the understanding of therapeutic approaches for ovarian cancer, with the ultimate completion date of June 30, 2026. As a leading Australian research...
- Federal Grant Award Summary La Trobe University received a $669,102 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of April 1, 2026 through March 31, 2029. The award supports research utilizing novel biological therapies to target a tumor-specific isoform of HER2 (Human Epidermal Growth Factor Receptor 2) for the treatment of advanced breast cancer. This three-year research initiative will be...